Primidone
NDC Package 68682-690-10
Package Information
Primidone is a medication used alone or with other medications to control seizures. Marketed by Oceanside Pharmaceuticals, this product is identified by NDC 68682-690 and is authorized under FDA application NDA009170.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68682 - Oceanside Pharmaceuticals
- 68682-690 - Primidone
- 68682-690-10 - 100 TABLET in 1 BOTTLE
- 68682-690 - Primidone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68682-690-10 identifies a specific commercial package of 100 tablet in 1 bottle of Primidone, labeled by Oceanside Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Oceanside Pharmaceuticals on May 21, 2018. The current certification is valid through December 31, 2020.
What are the primary indications for this medication?
This medication is used alone or with other medications to control seizures. Controlling and reducing seizures lets you do more of your normal daily activities, reduces your risk of harm when you lose consciousness, and lessens your risk for a possibly life-threatening condition of frequent, repeated seizures. Primidone belongs to a class of drugs known as barbiturate anticonvulsants. It works by controlling the abnormal electrical activity in the brain that occurs during a seizure.
How is this Oceanside Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68682069010. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.